Hip fracture is generally considered to be the most devastating outcome of osteo porosis. in 1990, 1.66 million hip fractures were reported worldwide-a number that is predicted to rise to 6.3 million by 2050. 1 lowtrauma hip fractures occur mainly in elderly patients, at a mean age of 80. the burden of hip fracture management on both the individual and society is substan tial, and is estimated to cost us$21,000 in the first year alone. 2 this expenditure includes direct fracturetreatment costs and social costs owing to functional impairment and increased morbidity. Hip fractures are associ ated with a high risk of death (par ticularly during the immediate post fracture years) that is dependent on both the prefracture health status of the patient and the postfracture medical consequences such as infections, cardiovascular events and thromboembolism.
to elucidate the excess mortality related to hip fracture, Haentjens et al. 3 performed a metaanalysis in which the data from patients with hip fractures were stratified by both sex and time. overall, 22 cohorts of women and 17 cohorts of men over the age of 50 at the time of hip fracture (and with mortality data available) were included-a total of >500,000 individual patients from registrybased and casebased studies performed in the usa or europe. the study included both shortterm (<2 years) and longterm (≤10 years) analyses. as expected, initial mortality following hip fracture was high. in women, a fivefold increased risk for allcause mor tality during the first 3 months postfracture was reported, while men had an eightfold increase over the same time period. excess mortality persisted after hip fracture at each time interval analyzed (1, 2, 5 and 10 years postfracture). at ≥2 years postfracture, the relative increase for allcause mortality was about 2.5fold and twofold in men and women, respectively, in comparison with the control population-a ratio that was sustained for up to 10 years.
in terms of absolute risk of death, Haentjens et al. 3 created a model based on survival data from us patients with hip fracture, and mortality risk estimates were presented for an 80yearold individual with a hip fracture. their findings suggest that a woman who meets the stated criteria has an absolute annual mortality risk of 8%, 11%, 18% and 22% at 1, 2, 5 and 10 years post fracture, respectively, whereas a man has a corresponding absolute risk of 18%, 22%, 26% and 20%.
this study shows that excess mor tality following hip fracture is sustained at a steady rate during 2-10 years of followup and is similar for men and women. in the shortterm (≤12 months postfracture) the high excess mortality slowly decreases, but remains higher in men compared with women over the entire first year. this latter finding is a wellknown phenomenonmale patients who undergo hip fracture are frailer before fracture than female patients, which inflicts an increased risk in the postoperative and the postfracture management periods. Comorbidities associ ated with frailty and mortality in patients with hip fracture include cardiovascular disease, infection, thromboembolism and re currence of fractures.
although the metaanalysis by Haentjens et al. 3 was a wellconducted systematic study, it has some limitations (as acknow ledged by the authors). the studies included in the analysis were performed at dif ferent timeperiods; the reported shortterm mortality results might, therefore, have been influenced by the overall fracture manage ment at the time when the study was per formed. nevertheless, the presented data are clearly consistent despite the range of observation periods. this study highlights the importance of stratifying risk by sex when analyzing data from patients with hip fracture. However, stratification of the data by patient age at the time of fracture would also have been beneficial, since mortality is clearly influenced by the age of the patient when a fracture occurs. 4 Furthermore, the mean age at occurrence of hip fracture is increasing, and very elderly individuals (>90 years of age) are becoming a propor tionally larger subgroup of all patients with hip fracture. 3 provide an important contribution to the knowledge concerning patients with hip fracture and their find ings might have clinical utility. indeed, the implications of this metaanalysis reinforce the recommendations of previous guide lines and initiatives promoting improved manage ment in this vulnerable population of patients.
6,7 the longterm mortality of individuals with hip fracture highlights the need to consider factors at the time of frac ture, such as comorbidities, to improve the longterm outcome. the increased risk of further fractures adding to morbidity and mortality is another important consider tion, and standardized secon dary preven tion programs should reduce this risk. nevertheless, by providing a comprehen sive account of excess mortality, this study underlines the need for improved care for patients with hip fracture, both before surgery and after surgery, to reduce the risk of death.
